Suppr超能文献

LncRNA ZEB1-AS1/miR-409-3p/ZEB1 反馈环路参与非小细胞肺癌的进展。

LncRNA ZEB1-AS1/miR-409-3p/ZEB1 feedback loop is involved in the progression of non-small cell lung cancer.

机构信息

Cheeloo College of Medicine, Shandong University, Jinan, 250100, PR China.

School of Basic Medical Sciences, Shandong University, Jinan, 250100, PR China.

出版信息

Biochem Biophys Res Commun. 2018 Dec 9;507(1-4):450-456. doi: 10.1016/j.bbrc.2018.11.059. Epub 2018 Nov 15.

Abstract

Emerging evidence has illustrated that long noncoding RNA (LncRNA) ZEB1 antisense RNA 1 (ZEB1-AS1) involved in the development of various type of human cancers. However, the role of ZEB1-AS1 in non-small cell lung cancer (NSCLC) is still elusive and poorly understood. The present study aimed to provide functional evidence and elucidate the molecular mechanisms by which the ZEB1-AS1 promotes oncogenesis of NSCLC. Our study found that ZEB1-AS1 was upregulated in NSCLC cells and knockdown of ZEB1-AS1 significantly inhibited cell growth and induced cell apoptosis. Mechanically, miR-409-3p was confirmed as a direct target of ZEB1-AS1 and negatively regulated by ZEB1-AS1 via competing endogenous RNA (ceRNA) mechanism; miR-409-3p inhibited ZEB1 expression by directly binding to the 3'UTR. Importantly, as predicted by JASPAR and further confirmed by luciferase reporter gene and ChIP assays, we found ZEB1 could bind to the promoter region of ZEB1-AS1 to activate its expression. Restoration of ZEB1 could partially abolished the action of ZEB1-AS1 silencing on cell proliferation and apoptosis. Collectively, the results suggested that ZEB1-AS1/miR-409-3p/ZEB1 constitutes a positive feedback loop to promote the tumorigenesis of NSCLC, highlighting the possibility of improving NSCLC treatment by targeting the ZEB1-AS1 signaling pathway.

摘要

越来越多的证据表明,长链非编码 RNA(LncRNA)ZEB1 反义 RNA 1(ZEB1-AS1)参与了多种人类癌症的发生发展。然而,ZEB1-AS1 在非小细胞肺癌(NSCLC)中的作用仍不清楚。本研究旨在提供功能证据,并阐明 ZEB1-AS1 促进 NSCLC 致癌作用的分子机制。我们的研究发现,ZEB1-AS1 在 NSCLC 细胞中上调,敲低 ZEB1-AS1 显著抑制细胞生长并诱导细胞凋亡。从机制上讲,miR-409-3p 被确认为 ZEB1-AS1 的直接靶标,并通过竞争性内源性 RNA(ceRNA)机制被 ZEB1-AS1 负调控;miR-409-3p 通过直接结合 3'UTR 抑制 ZEB1 表达。重要的是,正如 JASPAR 预测的,并进一步通过荧光素酶报告基因和 ChIP 实验证实的,我们发现 ZEB1 可以结合 ZEB1-AS1 的启动子区域来激活其表达。ZEB1 的恢复可以部分消除 ZEB1-AS1 沉默对细胞增殖和凋亡的作用。总之,这些结果表明,ZEB1-AS1/miR-409-3p/ZEB1 构成一个正反馈环,促进 NSCLC 的肿瘤发生,提示通过靶向 ZEB1-AS1 信号通路改善 NSCLC 治疗的可能性。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验